Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome

被引:20
|
作者
Momose, I
Umezawa, Y
Hirosawa, S
Iijima, M
Iinuma, H
Ikeda, D
机构
[1] Microbial Chem Res Ctr, Numazu Biomed Res Inst, Shizuoka 4100301, Japan
[2] Microbial Chem Res Ctr, Shinagawa Ku, Tokyo 1410021, Japan
[3] Microbial Chem Res Ctr, Hiyoshi Med Chem Res Inst, Nakahara Ku, Kawasaki, Kanagawa 2110035, Japan
关键词
proteasome inhibitor; tyropeptin A derivative;
D O I
10.1271/bbb.69.1733
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tyropeptin A, a potent proteasome inhibitor, was isolated from the culture broth of Kitasatospora sp. MK993-dF2. We synthesized the derivatives of tyropeptin A to enhance its inhibitory potency. Among the synthesized derivatives, the most potent compound, TP-104, exhibited a 20-fold inhibitory potency enhancement for chymotrypsin-like activity of 20S proteasome compared to tyropeptin A. Additionally, TP-110 specifically inhibited the chymotrypsin-like activity, but did not inhibit the post-glutamyl-peptide hydrolyzing (PGPH) and the trypsin-like activities of 20S proteasome. In vitro TP-110 strongly inhibited the growth of various cell lines.
引用
收藏
页码:1733 / 1742
页数:10
相关论文
共 50 条
  • [41] 20S proteasome biogenesis
    Krüger, E
    Kloetzel, PM
    Enenkel, C
    BIOCHIMIE, 2001, 83 (3-4) : 289 - 293
  • [42] Design and synthesis of 2-aminobenzylstatine-based inhibitors of the chymotrypsin-like activity of the 20S proteasome.
    Garcia-Echeverria, C
    Imbach, P
    Roesel, J
    Fürst, P
    Lang, M
    Guagnano, V
    Noorani, M
    Zimmermann, J
    Furet, P
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3727S - 3727S
  • [43] Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors
    Momose, Isao
    Abe, Hikaru
    Watanabe, Takumi
    Ohba, Shun-ichi
    Yamazaki, Kanami
    Dan, Shingo
    Yamori, Takao
    Masuda, Tohru
    Nomoto, Akio
    CANCER SCIENCE, 2014, 105 (12): : 1609 - 1615
  • [44] 20S proteasome and its inhibitors: Crystallographic knowledge for drug development
    Borissenko, Ljudmila
    Groll, Michael
    CHEMICAL REVIEWS, 2007, 107 (03) : 687 - 717
  • [45] Inhibitors of the Eukaryotic 20S Proteasome Core Particle: a Structural Approach
    Groll, Michael
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C119 - C119
  • [46] NON-COVALENT PEPTIDIC INHIBITORS OF HUMAN 20S PROTEASOME
    Debowski, D.
    Karna, N.
    Gitlin, A.
    Lubos, M.
    Legowska, A.
    Rolka, K.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S295 - S295
  • [47] Cystargolides, 20S Proteasome Inhibitors Isolated from Kitasatospora cystarginea
    Gill, Krista A.
    Berrue, Fabrice
    Arens, Jennifer C.
    Carr, Gavin
    Kerr, Russell G.
    JOURNAL OF NATURAL PRODUCTS, 2015, 78 (04): : 822 - 826
  • [48] Analogues of SFTI-1 as the potential inhibitors of the 20S proteasome
    Debowski, D.
    Mizeria, A.
    Lesner, A.
    Legowska, A.
    Rolka, K.
    JOURNAL OF PEPTIDE SCIENCE, 2012, 18 : S92 - S92
  • [49] Pharmacologic evaluation of orally bioavailable inhibitors of the 20S proteasome.
    Kirk, Christopher J.
    Aujay, Monette A.
    Ho, Mark
    Jiang, Jing
    Laidig, Guy J.
    Lewis, Evan R.
    Lu, Yan
    Muchamuel, Tony
    Woo, Tina M.
    Sun, Congcong M.
    Sylvain, Catherine
    Yang, Jinfu
    Zhou, Han-jie
    Bennett, Mark K.
    BLOOD, 2006, 108 (11) : 1023A - 1023A
  • [50] A class of non-competitive inhibitors for 20S proteasome.
    Wang, L
    Joly, A
    Meyer, S
    Lum, RT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U213 - U213